-
G287070-1mgInhibitor of γ-glutamyl transpeptidase (GGT).
-
G287070-25mgInhibitor of γ-glutamyl transpeptidase (GGT).
-
G287070-50mgInhibitor of γ-glutamyl transpeptidase (GGT).
-
G287070-5mgInhibitor of γ-glutamyl transpeptidase (GGT).
-
G115869-15mgGinkgolic Acids(C13:0,C15:1,C17:2,C15:0,C17:1).
-
G287266-10mgGlucokinase activator.
-
-
G287266-25mgGlucokinase activator.
-
-
Ab175888-100μgGlembatumumab (anti-GPNMB) is a fully human IgG2 monoclonal antibody directed against the extracellular structural domain of GPNMB expressed in human breast cancer and melanoma. Glembatumumab (anti-GPNMB) can be coupled to the microtubule inhibitor
-
G288570-10mgproduct description:GLPG0187 is a broad spectrum integrin receptor antagonist with antitumor activity: inhibits αvβ1-integrin with an IC50 of 1.3 nM.
-
G288570-25mgproduct description:GLPG0187 is a broad spectrum integrin receptor antagonist with antitumor activity: inhibits αvβ1-integrin with an IC50 of 1.3 nM.